We selected the possible effective combination of inhibitors using a 3D HTS platform and blocked the downstream (mTOR inhibitor) and upstream (AKT inhibitor) mediators of the PI3K/AKT/mTOR pathway in bladder cancer cells. The gene discussed is AKT1; the disease is urinary bladder carcinoma.